Determinants of health-related quality of life and global functioning and health in axSpA, pSpA, and PsA: results from the ASAS-PerSpA study (2023)
https://pubmed.ncbi.nlm.nih.gov/37739573/

Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis. (2023)
https://pubmed.ncbi.nlm.nih.gov/37663034/

Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial. (2023)
https://pubmed.ncbi.nlm.nih.gov/37407237/

Instrument selection for the ASAS core outcome set for axial spondyloarthritis. (2023)
https://pubmed.ncbi.nlm.nih.gov/35680390/

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. (2023)
https://pubmed.ncbi.nlm.nih.gov/36787993/

Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort. (2023)
https://pubmed.ncbi.nlm.nih.gov/35951746/

Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort. (2023)
https://pubmed.ncbi.nlm.nih.gov/35951746/

Predictors of remission in people with axial spondyloarthritis: A systematic literature review. (2022)
https://pubmed.ncbi.nlm.nih.gov/35944350/

The ASAS-OMERACT core domain set for axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility (2021)
https://pubmed.ncbi.nlm.nih.gov/33523107/

Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort (2021)
https://pubmed.ncbi.nlm.nih.gov/34172511/

Axial Spondyloarthritis: Mimics and Pitfalls of Imaging Assessment. (2021)
https://pubmed.ncbi.nlm.nih.gov/33849999/

Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies (2021)
https://pubmed.ncbi.nlm.nih.gov/33351179/

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable (2021)
https://pubmed.ncbi.nlm.nih.gov/32572483/

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

No relationship between bone mineral density and syndesmophyte formation at the same level in the lumbar spine of patients with radiographic axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33310864/

Long-term association between disease activity and disability in early axial spondyloarthritis: results from the DESIR cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/33207078/

Validity and reliability of a sensor-based electronic spinal mobility index for axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32342100/

Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohort (2020)
https://pubmed.ncbi.nlm.nih.gov/33060191/

Recent advances in managing axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32704350/

Measuring Spinal Mobility Using an Inertial Measurement Unit System: A Validation Study in Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32599741/

Response to lower dose TNF inhibitors in axial spondyloarthritis; a real-world multicentre observational study (2020)
https://pubmed.ncbi.nlm.nih.gov/32793854/

Classification Criteria in Axial Spondyloarthritis: What Have We Learned; Where Are We Going? (2020)
https://pubmed.ncbi.nlm.nih.gov/32340700/

Educational needs in people with ankylosing spondylitis and psoriatic arthritis: a cross-sectional study (2020)
https://pubmed.ncbi.nlm.nih.gov/31365330/

Inhibition of interleukin-17 in axial spondyloarthritis spectrum (2020)
https://pubmed.ncbi.nlm.nih.gov/31813638/

The European Portuguese version of the ASAS Health Index for Patients with Spondyloarthritis: Measurement properties (2020)
https://pubmed.ncbi.nlm.nih.gov/32572012/

Development and validation of psoriatic arthritis switch quality assessment tool (PASQAL) – an outcomes measurement tool to assess the quality of biologic switch decisions in psoriatic arthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32578579/

Performance of magnetic resonance imaging in the diagnosis of axial spondyloarthritis: a systematic literature review (2019)
https://pubmed.ncbi.nlm.nih.gov/31046102/

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group (2019)
https://pubmed.ncbi.nlm.nih.gov/31422357/

Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK (2019)
https://pubmed.ncbi.nlm.nih.gov/31046100/

How to investigate: Early axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/31810544/

Treat-to-target in axial spondyloarthritis: gold standard or fools’ gold? (2019)
https://pubmed.ncbi.nlm.nih.gov/31090589/

Performance of referral strategies for spondyloarthritis: a population-based nationwide study (2019)
https://pubmed.ncbi.nlm.nih.gov/30649551/

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states (2018)
https://pubmed.ncbi.nlm.nih.gov/29453216/

Biologics for treating axial spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29681195/

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial (2018)
https://pubmed.ncbi.nlm.nih.gov/29343510/

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force (2018)
https://pubmed.ncbi.nlm.nih.gov/28684559/